ROIVANT SCIENCES LTD. Noncontrolling Interest, Increase from Subsidiary Equity Issuance
ROIVANT SCIENCES LTD. (ROIV) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $87.50 million for the 12-month period ending 2023-03-31, per its 10-K filed 2025-05-29.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2025-05-29
- ROIVANT SCIENCES LTD. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2022-12-31 was $87.50M.
- ROIVANT SCIENCES LTD. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2021-09-30 was $70.00M.
- ROIVANT SCIENCES LTD. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2023 was $87.50M, a 25.00% increase from fiscal 2022.
- ROIVANT SCIENCES LTD. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2022 was $70.00M.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|
| 2023-03-31 | $87.50M 10-K · filed 2025-05-29 | |
| 2022-12-31 | $87.50M 10-Q · filed 2024-02-13 | |
| 2022-03-31 | $70.00M 10-K · filed 2023-06-28 | |
| 2021-09-30 | $70.00M 10-Q · filed 2023-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |